Notoginsenoside R1 relieves the myocardial infarction via activating the JAK2/STAT3 signaling pathway in vivo and in vitro

Myocardial infarction (MI), caused by continuous ischemia and hypoxia of the coronary artery, is one of the major causes of human mortality. This study aimed to investigate the role of notoginsenoside R1 (NGR1) in MI therapy. In vitro and in vivo models of MI were established by hypoxia/reoxygenatio...

Descripción completa

Detalles Bibliográficos
Autores principales: Xu, Hai, Zhang, Xiwen, Shi, Yafei, Yu, Kun, Jiang, Yicheng
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2022
Materias:
Research Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974102/
https://www.ncbi.nlm.nih.gov/pubmed/35263202
http://dx.doi.org/10.1080/21655979.2022.2037366

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8974102/
https://www.ncbi.nlm.nih.gov/pubmed/35263202
http://dx.doi.org/10.1080/21655979.2022.2037366

Ejemplares similares